Grant: Project Grant
Centre hospitalier de l'Université de Montréal (CHUM)
$707,625.00
Prevention and treatment of preeclampsia using exercise training and Angiotensin-(1-7): determining the mechanisms and clinical potential
EF 2019-20
Résumé
Preeclampsia is a pregnancy-associated disease where women develop high blood pressure and protein in their urine. It is the leading cause of mother and fetus mortality and morbidity. In addition, children born to preeclamptic mothers have a higher risk of high blood pressure as adults and women who have had preeclampsia are more at risk of developing several cardiovascular diseases. However, we have yet to identify its specific cause as well as methods for early detection and prevention. Women who have high blood pressure are more at risk of developing preeclampsia. Because of the difficulties imposed by this human
disease, animal models of preeclampsia have been developed although there are very few who develop the disease spontaneously. We have discovered a new mouse model which has the same symptoms as women who suffer from high blood pressure and go on to develop
preeclampsia when they become pregnant. In addition, we have recently produced data that suggest new molecules that could be implicated in this disease. As such, we wish to further investigate these elements and determine if they may be used as therapeutic targets using our animal model which would have an important clinical impact as there is no effective treatment for this disease apart from early delivery.
Programme
Project Grant
Emplacement
Quebec, Canada
Type de bénéficiaire
Not-for-profit organization or charity
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
409783
Name
Lavoie Julie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - B: Heart and Circulation
Projecttitle
Prevention and treatment of preeclampsia using exercise training and Angiotensin-(1-7): determining the mechanisms and clinical potential
Programtype2
Operating Grants
Orgnameinp2
Centre hospitalier de l'Université de Montréal (CHUM)
Cihramount2
$707,625
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Adipose Tissue; Arterial Blood Pressure; Cardiac Function; Exercise Training (Voluntary Wheel); Hypertension; Placenta; Preeclampsia; Renin-Angiotensin System; Telemetry; Transgenic Mice
Abstract
Preeclampsia is a pregnancy-associated disease where women develop high blood pressure and protein in their urine. It is the leading cause of mother and fetus mortality and morbidity. In addition, children born to preeclamptic mothers have a higher risk of high blood pressure as adults and women who have had preeclampsia are more at risk of developing several cardiovascular diseases. However, we have yet to identify its specific cause as well as methods for early detection and prevention. Women who have high blood pressure are more at risk of developing preeclampsia. Because of the difficulties imposed by this human
disease, animal models of preeclampsia have been developed although there are very few who develop the disease spontaneously. We have discovered a new mouse model which has the same symptoms as women who suffer from high blood pressure and go on to develop
preeclampsia when they become pregnant. In addition, we have recently produced data that suggest new molecules that could be implicated in this disease. As such, we wish to further investigate these elements and determine if they may be used as therapeutic targets using our animal model which would have an important clinical impact as there is no effective treatment for this disease apart from early delivery.
Competitiondate
201909
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Lavoie, Julie
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $707,625~ $0~